Netflix, Inc. (ETR:NFC)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	421,278	368,010	192,789	122,790	234,643	195,294
Market Cap Growth	78.80%	90.89%	57.01%	-47.67%	20.15%	54.55%
Enterprise Value	428,657	376,978	200,838	132,445	243,858	203,260
Last Close Price	1001.20	859.90	442.40	268.75	540.90	431.40
PE Ratio	48.28	43.74	39.40	29.21	52.16	86.51
PS Ratio	11.87	9.77	6.32	4.15	8.99	9.56
PB Ratio	19.83	15.40	10.35	6.32	16.84	21.59
P/TBV Ratio	39.02	30.92	27.09	16.31	130.17	-
P/FCF Ratio	-	55.04	30.77	81.08	-	123.83
P/OCF Ratio	-	51.76	29.30	64.76	679.69	98.43
EV/Sales Ratio	11.90	10.01	6.58	4.48	9.34	9.95
EV/EBITDA Ratio	37.30	36.32	30.37	23.71	43.31	52.89
EV/EBIT Ratio	40.34	37.46	31.92	25.13	44.77	54.23
EV/FCF Ratio	59.22	56.39	32.05	87.45	-	128.88
Debt / Equity Ratio	0.68	0.73	0.82	0.82	1.14	1.67
Debt / EBITDA Ratio	1.27	1.58	2.14	2.57	2.61	3.60
Debt / FCF Ratio	1.99	2.60	2.45	10.46	-	9.60
Asset Turnover	0.82	0.76	0.69	0.68	0.71	0.68
Quick Ratio	1.12	1.08	1.01	0.96	0.81	1.13
Current Ratio	1.34	1.22	1.12	1.17	0.95	1.25
Return on Equity (ROE)	43.55%	38.44%	26.15%	24.53%	38.02%	29.62%
Return on Assets (ROA)	15.05%	12.72%	8.93%	7.56%	9.23%	7.82%
Return on Capital (ROIC)	19.10%	16.22%	11.55%	9.82%	12.19%	10.71%
Return on Capital Employed (ROCE)	27.90%	24.30%	17.40%	13.90%	17.20%	14.60%
Earnings Yield	2.07%	2.29%	2.54%	3.42%	1.92%	1.16%
FCF Yield	1.72%	1.82%	3.25%	1.23%	-0.05%	0.81%
Buyback Yield / Dilution	1.57%	2.28%	0.40%	0.90%	-0.26%	-0.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.